Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beau R Webber

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Cytotherapy|January 12, 2023
CRISPR-Cas9 base editors and their current role in human therapeuticsWalker S Lahr, Christopher J Sipe, Joseph G Skeate, et al.
Journal of Autoimmunity|January 20, 2025
CAR-T cell targeting three receptors on autoreactive B cells for systemic lupus erythematosus therapyVinayak Uppin, Hunter Gibbons, Marissa Troje, et al.
Journal of Visualized Experiments : Jove|November 23, 2020
Genome Engineering of Primary Human B Cells Using CRISPR/Cas9Kanut Laoharawee, Matthew J Johnson, Walker S Lahr, et al.
Stem Cell Reports|August 29, 2017
Dermatopontin in Bone Marrow Extracellular Matrix Regulates Adherence but Is Dispensable for Murine Hematopoietic Cell MaintenanceAshley C Kramer, Amanda L Blake, Mandy E Taisto, et al.
Stem Cells (Dayton, Ohio)|August 1, 2015
In Vitro T-Cell Generation From Adult, Embryonic, and Induced Pluripotent Stem Cells: Many Roads to One DestinationMichelle J Smith, Beau R Webber, Mahmood Mohtashami, et al.
International Journal of Cancer|May 7, 2021
Comparative international incidence of Ewing sarcoma 1988 to 2012Logan G Spector, Aubrey K Hubbard, Brandon J Diessner, et al.
International Journal of Molecular Sciences|June 15, 2017
CRISPR/Cas9-Mediated Correction of the FANCD1 Gene in Primary Patient CellsKarolina Skvarova Kramarzova, Mark J Osborn, Beau R Webber, et al.
The CRISPR Journal|April 26, 2019
EditR: A Method to Quantify Base Editing from Sanger SequencingMitchell G Kluesner, Derek A Nedveck, Walker S Lahr, et al.
Molecular Therapy. Oncology|October 27, 2025
Installation of dominant-negative mutations in <i>FAS</i> and <i>TGFβR2</i> via base editing in primary T cellsBryce J Wick, Mitchell G Kluesner, Nicholas J Slipek, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Installation of Dominant-Negative Mutations in <i>FAS</i> and <i>TGFβR2</i> via Base Editing in Primary T CellsBryce J Wick, Mitchell G Kluesner, Nicholas J Slipek, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Cytotherapy|January 12, 2023
CRISPR-Cas9 base editors and their current role in human therapeuticsWalker S Lahr, Christopher J Sipe, Joseph G Skeate, et al.
Journal of Autoimmunity|January 20, 2025
CAR-T cell targeting three receptors on autoreactive B cells for systemic lupus erythematosus therapyVinayak Uppin, Hunter Gibbons, Marissa Troje, et al.
Journal of Visualized Experiments : Jove|November 23, 2020
Genome Engineering of Primary Human B Cells Using CRISPR/Cas9Kanut Laoharawee, Matthew J Johnson, Walker S Lahr, et al.
Stem Cell Reports|August 29, 2017
Dermatopontin in Bone Marrow Extracellular Matrix Regulates Adherence but Is Dispensable for Murine Hematopoietic Cell MaintenanceAshley C Kramer, Amanda L Blake, Mandy E Taisto, et al.
Stem Cells (Dayton, Ohio)|August 1, 2015
In Vitro T-Cell Generation From Adult, Embryonic, and Induced Pluripotent Stem Cells: Many Roads to One DestinationMichelle J Smith, Beau R Webber, Mahmood Mohtashami, et al.
International Journal of Cancer|May 7, 2021
Comparative international incidence of Ewing sarcoma 1988 to 2012Logan G Spector, Aubrey K Hubbard, Brandon J Diessner, et al.
International Journal of Molecular Sciences|June 15, 2017
CRISPR/Cas9-Mediated Correction of the FANCD1 Gene in Primary Patient CellsKarolina Skvarova Kramarzova, Mark J Osborn, Beau R Webber, et al.
The CRISPR Journal|April 26, 2019
EditR: A Method to Quantify Base Editing from Sanger SequencingMitchell G Kluesner, Derek A Nedveck, Walker S Lahr, et al.
Molecular Therapy. Oncology|October 27, 2025
Installation of dominant-negative mutations in <i>FAS</i> and <i>TGFβR2</i> via base editing in primary T cellsBryce J Wick, Mitchell G Kluesner, Nicholas J Slipek, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Installation of Dominant-Negative Mutations in <i>FAS</i> and <i>TGFβR2</i> via Base Editing in Primary T CellsBryce J Wick, Mitchell G Kluesner, Nicholas J Slipek, et al.
Pageof 8